Endocrine Abstracts

Background: It is generally reported that female fertility is not affected by high-dose RAI treatment. AMH has been considered a reliable and accurate index of ovarian reserve. There are few data on AMH values in thyroid diseases. Recently, in DTC women who had undergone RAI ablation treatment, Acibucu et al. (2016) reported low AMH levels without significant impairment of fertility.Aim: The aim of this single-center study was to evaluate AMH le...

Introduction: Patients with acromegaly have an increased fracture risk, particularly vertebral fractures. Growth hormone (GH) excess, and the related increase of IGF-1 levels, have been shown to impair bone microarchitecture more than bone density. Therefore, the assessment of trabecular bone score (TBS) has been recommended beside standard dual-energy X-ray absorptiometry (DXA). The calcaneal quantitative ultrasound (QUS) is less expensive and more accessible compared to DXA,...

The impact of GH/IGF-1 levels on skeletal muscle in patients with acromegaly is still matter of debate. Recently, temporal (TMT) and masseter muscle thickness (MMT) have emerged as reliable indicators of muscle mass, as well as patients’ functional status/prognosis in various clinical context – especially in the oncologic setting. This study aims to investigate the potential correlations between TMT/MMT and patients’ demographic and clinical characteristics. A r...

Introduction: Immunohistochemistry (IHC) of somatostatin receptor subtype 2 (SST2) is a predictive factor for first-generation somatostatin receptor ligand (fg-SRL) response in acromegaly patients. A semi-quantitative immunoreactivity score, IRS, has been proposed as the gold-standard to evaluate SST2 IHC expression. Recently, our group developed a quantitative method to determine SST2 expression using an open-source digital image analysis (DIA...